اختلال سوء مصرف مواد مخدر و نحوه مدیریت آن در زنان دارای سابقه سزارین: یک مرور نظام‌مند از مقالات مروری نقلی

نوع مقاله : مروری

نویسندگان

1 کارشناس ارشد علوم تشریح، دانشکده پزشکی، دانشگاه علوم پزشکی تبریز، تبریز، ایران.

2 استادیار گروه بیهوشی، مرکز تحقیقات سل و بیماری‌های ریوی، دانشکده پزشکی، دانشگاه علوم پزشکی تبریز، تبریز، ایران.

چکیده

مقدمه: زنان مبتلا به اختلال سوء مصرف مواد مخدر احتمالاً حین و پس از زایمان به مقادیر بیشتری از مواد مخدر برای بی‌دردی نیاز دارند؛ با این‌حال به‌دلیل محدود بودن تعداد مطالعات در این زمینه، مطالعه حاضر با هدف اختلال سوء مصرف مواد مخدر و نحوه مدیریت آن در زنان با سابقه سزارین انجام شد.
روش‌کار: در این مطالعه مرور سیستماتیک که در طی بازه زمانی سال 2000 تا شش ماهه ابتدایی سال 2022 انجام شد، جهت یافتن مقالات مرتبط (منتشر شده به دو زبان فارسی و انگلیسی) پایگاه­ های اطلاعاتی PubMed،EMBASE ، Cochrane Library، Web Of science، Scopus، Mag-Iran و SID با کلیدواژه ­های درد، شدت درد، درد حاد، درد مزمن اوپیوئید، سزارین، زایمان سزارین، اختلال سوء مصرف مواد مخدر، مدیریت درد، پیشگیری و بی‌دردی مورد جستجو قرار گرفتند.
یافته ­ها: زنان با سابقه سزارین که دارای اختلالات مصرف مواد مخدر هستند، با چالش‌های منحصر به‌فردی در دسترسی به درمان و حمایت مناسب مواجه می‌باشند. نتایج بر اهمیت مدل‌های مراقبت تلفیقی را که هم جنبه‌های فیزیکی و هم جنبه‌های روانی مدیریت اختلال مصرف مواد را مورد توجه قرار می‌دهند، تمرکز دارند. علاوه بر این، مداخلات تخصصی متناسب با نیازهای این جمعیت، مانند مراقبت‌های آگاهانه از تروما و برنامه‌های مصرف مواد پری‌ناتال، در بهبود نتایج مؤثر می‌باشند.
نتیجه ­گیری: کنترل بهینه درد پس از سزارین در زنان با اختلال سوء مصرف مواد مخدر شامل یک استراتژی چندوجهی با استفاده از مواد مخدر داخل نخاعی یا اپیدورال، استامینوفن و عوامل ضدالتهاب غیراستروئیدی به‌عنوان خط اول است.

کلیدواژه‌ها

عنوان مقاله [English]

Drug use disorder and its management in women with a history of caesarean section: A systematic review of narrative review articles

نویسندگان [English]

  • Mina Zeynalzade 1
  • Mehdi Nazari 2
  • Mansour Rezaei 2
1 M.Sc. of Anatomical Sciences, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
2 Assistant Professor, Department of Anesthesiology, Tuberculosis and Lung Disease Research Center, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
چکیده [English]

Introduction: Women with drug use disorder probably need larger amounts of drugs for analgesia during and after childbirth; however, due to the limited number of studies in this field, the present study was conducted with aim to evaluate drug use disorder and how to manage it in women with history of caesarean section.
Methods: In this systematic review study which was conducted during 2000 until the first six months of 2022, in order to find related articles (published in both Persian and English), databases of PubMed, EMBASE, Cochrane Library, Web Of Science, Scopus, Mag-Iran and SID were searched using the keywords of pain, pain intensity, acute pain, chronic opioid pain, cesarean section, cesarean delivery, drug abuse disorder, pain management, prevention and analgesia.
Results: Women with a history of caesarean who had drug use disorders faced unique challenges in accessing appropriate treatment and support. The results focused on the importance of integrated care models that addressed both the physical and psychological aspects of drug use disorder management. Additionally, specialized interventions tailored to the needs of this population, such as trauma-informed care and perinatal substance use programs, were found to be effective in improving outcomes.
Conclusion: Optimal control of post-cesarean pain in women with drug abuse disorder includes a multifaceted strategy using intrathecal or epidural drugs, acetaminophen and non-steroidal anti-inflammatory agents as the first line.

کلیدواژه‌ها [English]

  • Cesarean section
  • Drug use disorder
  • Management
  • Pain

مراجع

  1. Haight SC, Ko JY, Tong VT, Bohm MK, Callaghan WM. Opioid use disorder documented at delivery hospitalization—United States, 1999–2014. Morbidity and Mortality Weekly Report 2018; 67(31):845-9.
  2. Rezaei S, Naghipour B, Rezaei M, Dadashzadeh M, Sadeghi S. Chemical evaluation of gastrointestinal, coronary and pulmonary complications in patients admitted to the intensive care unit. Eurasian Chemical Communications 2022: 557-66.
  3. Ladha KS, Patorno E, Liu J, Bateman BT. Impact of perioperative epidural placement on postdischarge opioid use in patients undergoing abdominal surgery. Anesthesiology 2016; 124(2):396-403.
  4. Ecker J, Abuhamad A, Hill W, Bailit J, Bateman BT, Berghella V, et al. Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic: a report of a joint workshop of the Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists, and American Society of Addiction Medicine. American Journal of Obstetrics & Gynecology 2019; 221(1):B5-28.
  5. Smith K, Lipari R. Women of Childbearing Age and Opioids. 2017 Jan 17. In: The CBHSQ Report. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2013.
  6. Bateman BT, Hernandez-Diaz S, Rathmell JP, Seeger JD, Doherty M, Fischer MA, et al. Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States. Anesthesiology 2014; 120(5):1216-24.
  7. Sun EC, Bateman BT, Memtsoudis SG, Neuman MD, Mariano ER, Baker LC. Lack of association between the use of nerve blockade and the risk of postoperative chronic opioid use among patients undergoing total knee arthroplasty: evidence from the Marketscan database. Anesthesia & Analgesia 2017; 125(3):999-1007.
  8. Ghojazadeh M, Paknezhad SP, Mohammadzadeh S, Vahed N, Rajabpour ZV, Rezaee M, et al. Dexmedetomidine for Procedural Sedation in the Emergency Department: A Systematic Review. Shiraz E-Medical Journal 2022; 23(1).
  9. Gallagher BK, Shin Y, Roohan P. Opioid prescriptions among women of reproductive age enrolled in Medicaid—New York, 2008–2013. Morbidity and Mortality Weekly Report 2016; 65(16):415-7.
  10. Schuckit MA. Treatment of opioid-use disorders. New England Journal of Medicine 2016; 375(4):357-68.
  11. Rezaee M, Sheghaghi Ilkhchi N, Zeinalzadeh M, Alvandfar D. The incidence of the symptoms of deep vein thrombosis in general anesthesia and spinal anesthesia after abdominal hysterectomy. Iran J Obstet Gynecol Infertil 2021; 24(11):45-51.
  12. Maeda A, Bateman BT, Clancy CR, Creanga AA, Leffert LR. Opioid abuse and dependence during pregnancy: temporal trends and obstetrical outcomes. Anesthesiology 2014; 121(6):1158-65.
  13. Hardt N, Wong TD, Burt MJ, Harrison R, Winter W, Roth J. Prevalence of Prescription and Illicit Drugs in Pregnancy‐Associated Non‐natural Deaths of Florida Mothers, 1999–2005. Journal of forensic sciences 2013; 58(6):1536-41.
  14. Stover MW, Davis JM. Opioids in pregnancy and neonatal abstinence syndrome. Semin Perinatol 2015; 39(7):561-5.
  15. Mobed A, Shirafkan M, Charsouei S, Sadeghzadeh J, Ahmadalipour A. Biosensors technology for anti-epileptic drugs. Clinica Chimica Acta 2022; 533:175-82.
  16. Delgado MK, Shofer FS, Patel MS, Halpern S, Edwards C, Meisel ZF, et al. Association between electronic medical record implementation of default opioid prescription quantities and prescribing behavior in two emergency departments. Journal of general internal medicine 2018; 33:409-11.
  17. Huybrechts KF, Bateman BT, Desai RJ, Hernandez-Diaz S, Rough K, Mogun H, et al. Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study. bmj 2017; 358.
  18. Desai RJ, Huybrechts KF, Hernandez-Diaz S, Mogun H, Patorno E, Kaltenbach K, et al. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study. Bmj 2015; 350.
  19. Charsouei S, Esfahlani MZ, Dorosti A, Zamiri RE. Effects of COVID-19 pandemic on perceived stress, quality of life, and coping strategies of women with breast cancer with spinal metastasis under chemotherapy. Int J Women's Health Reprod Sci 2021:55-60.
  20. Maughan BC, Hersh EV, Shofer FS, Wanner KJ, Archer E, Carrasco LR, et al. Unused opioid analgesics and drug disposal following outpatient dental surgery: a randomized controlled trial. Drug and alcohol dependence 2016; 168:328-34.
  21. Patrick SW, Dudley J, Martin PR, Harrell FE, Warren MD, Hartmann KE, et al. Prescription opioid epidemic and infant outcomes. Pediatrics 2015; 135(5):842-50.
  22. Fishman B, Daniel S, Koren G, Lunenfeld E, Levy A. Pregnancy outcome following opioid exposure: a cohort study. PLoS One 2019; 14(7):e0219061.
  23. Landau R. Post-cesarean delivery pain. Management of the opioid-dependent patient before, during and after cesarean delivery. International journal of obstetric anesthesia 2019; 39:105-16.
  24. Martin JA, Hamilton BE, Osterman MJ, Driscoll AK, Drake P. Births: final data for 2016. Natl Vital Stat Rep 2018; 67(1):1-55.
  25. Mohaddes G, Abdolalizadeh J, Babri S, Abedini N, Hossienzadeh F. The anti-edematous effect of ghrelin in brain hypoxia is associated with decreasing expression of vascular endothelial growth factor. Journal of Molecular Neuroscience 2015; 56:273-7.
  26. MacDorman MF, Menacker F, Declercq E. Cesarean birth in the United States: epidemiology, trends, and outcomes. Clinics in perinatology 2008; 35(2):293-307.
  27. Menacker F. Recent trends in cesarean delivery in the United States. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2010.
  28. Bateman BT, Cole NM, Maeda A, Burns SM, Houle TT, Huybrechts KF, et al. Patterns of opioid prescription and use after cesarean delivery. Obstetrics and gynecology 2017; 130(1):29.
  29. Atashkhoei S, Abedini N, Pourfathi H, Znoz AB, Marandi PH. Baricity of bupivacaine on maternal hemodynamics after spinal anesthesia for cesarean section: a randomized controlled trial. Iranian journal of medical sciences 2017; 42(2):136-43.
  30. Höflich AS, Langer M, Jagsch R, Bäwert A, Winklbaur B, Fischer G, et al. Peripartum pain management in opioid dependent women. European journal of pain 2012; 16(4):574-84.
  31. Whiteman VE, Salemi JL, Mogos MF, Cain MA, Aliyu MH, Salihu HM. Maternal opioid drug use during pregnancy and its impact on perinatal morbidity, mortality, and the costs of medical care in the United States. Journal of pregnancy 2014; 2014.
  32. Nezvalová-Henriksen K, Spigset O, Nordeng H. Effects of codeine on pregnancy outcome: results from a large population-based cohort study. European journal of clinical pharmacology 2011; 67:1253-61.
  33. Abedini N, Parish M, Farzin H, Pourfathi H, Akhsham M. The determination of an appropriate time for placement of the classic laryngeal mask airway in patients undergoing general anesthesia. Anesthesiology and pain medicine 2018; 8(2).
  34. Bateman BT, Mhyre JM, Hernandez-Diaz S, Huybrechts KF, Fischer MA, Creanga AA, et al. Development of a comorbidity index for use in obstetric patients. Obstetrics and gynecology 2013; 122(5).
  35. Miller EC, Zambrano Espinoza MD, Huang Y, Friedman AM, Boehme AK, Bello NA, et al. Maternal race/ethnicity, hypertension, and risk for stroke during delivery admission. Journal of the American Heart Association 2020; 9(3):e014775.
  36. Leonard SA, Abrams B, Main EK, Lyell DJ, Carmichael SL. Weight gain during pregnancy and the risk of severe maternal morbidity by prepregnancy BMI. The American Journal of Clinical Nutrition 2020; 111(4):845-53.
  37. López-de-Andrés A, Perez-Farinos N, Hernández-Barrera V, Palomar-Gallego MA, Carabantes-Alarcón D, Zamorano-León JJ, et al. A population-based study of diabetes during pregnancy in Spain (2009–2015): Trends in incidence, obstetric interventions, and pregnancy outcomes. Journal of clinical medicine 2020; 9(2):582.
  38. Thornton AT, Huang Y, Mourad MJ, Wright JD, D’Alton ME, Friedman AM. Obstetric outcomes among women with a liver transplant. The Journal of Maternal-Fetal & Neonatal Medicine 2021; 34(18):2932-7.
  39. Hashemzadeh K, Dehdilani M, Gol MK. Study of the effects of simple exercise with or without physiotherapy on prevention of deep vein thrombosis among postmenopausal women requiring coronary artery bypass graft surgery. Int J Womens Health Reprod Sci 2021; 9(1):69-74.
  40. Robinson HE, O’Connell CM, Joseph KS, McLeod NL. Maternal outcomes in pregnancies complicated by obesity. Obstetrics & Gynecology 2005; 106(6):1357-64.
  41. Leddy MA, Power ML, Schulkin J. The impact of maternal obesity on maternal and fetal health. Reviews in obstetrics and gynecology 2008; 1(4):170.
  42. Lutsiv O, Mah J, Beyene J, McDonald SD. The effects of morbid obesity on maternal and neonatal health outcomes: a systematic review and meta‐analyses. Obesity reviews 2015; 16(7):531-46.
  43. Suwal A, Shrivastava VR, Giri A. Maternal and fetal outcome in elective versus emergency cesarean section. Journal of the Nepal Medical Association 2013; 52(192).
  44. Yang XJ, Sun SS. Comparison of maternal and fetal complications in elective and emergency cesarean section: a systematic review and meta-analysis. Archives of gynecology and obstetrics 2017; 296:503-12.
  45. Hashemzadeh K, Dehdilani M, Gol MK. The Effect of Interval Training on Oxidative Stress Indices Among Women in Preterm Labor Underwent Coronary Artery Bypass Graft. International Journal of Women’s Health and Reproduction Sciences 2020; 8(4):406-11.
  46. Tangel V, White RS, Nachamie AS, Pick JS. Racial and ethnic disparities in maternal outcomes and the disadvantage of peripartum black women: a multistate analysis, 2007–2014. American journal of perinatology 2019; 36(08):835-48.
  47. Wagner JL, White RS, Tangel V, Gupta S, Pick JS. Socioeconomic, racial, and ethnic disparities in postpartum readmissions in patients with preeclampsia: a multi-state analysis, 2007–2014. Journal of Racial and Ethnic Health Disparities 2019; 6:806-20.
  48. Epstein RA, Bobo WV, Martin PR, Morrow JA, Wang W, Chandrasekhar R, et al. Increasing pregnancy-related use of prescribed opioid analgesics. Annals of epidemiology 2013; 23(8):498-503.
  49. Campbell CI, Weisner C, LeResche L, Ray GT, Saunders K, Sullivan MD, et al. Age and gender trends in long-term opioid analgesic use for noncancer pain. American journal of public health 2010; 100(12):2541-7.
  50. Desai RJ, Hernandez-Diaz S, Bateman BT, Huybrechts KF. Increase in prescription opioid use during pregnancy among Medicaid-enrolled women. Obstetrics and gynecology 2014; 123(5):997.
  51. Haghdoost SM, Gol MK. The necessity of paying more attention to the neurological and psychological problems caused by the COVID-19 pandemic during pregnancy. International Journal of Women's Health and Reproduction Sciences 2020; 8(3):243–244.
  52. Becker WC, Fiellin DA, Merrill JO, Schulman B, Finkelstein R, Olsen Y, et al. Opioid use disorder in the United States: insurance status and treatment access. Drug and alcohol dependence 2008; 94(1-3):207-13.
  53. Cooper S, Nielsen S. Stigma and social support in pharmaceutical opioid treatment populations: A scoping review. International Journal of Mental Health and Addiction 2017; 15(2):452-69.
  54. Schempf AH, Strobino DM. Drug use and limited prenatal care: an examination of responsible barriers. American journal of obstetrics and gynecology 2009; 200(4):412-e1.
  55. Shahidi N, Mahdavi F, Gol MK. Comparison of emotional intelligence, body image, and quality of life between rhinoplasty candidates and control group. Journal of Education and Health Promotion 2020; 9.
  56. Oser CB, Harp KL. Treatment outcomes for prescription drug misusers: The negative effect of geographic discordance. Journal of Substance Abuse Treatment 2015; 48(1):77-84.
  57. Saia KA, Schiff D, Wachman EM, Mehta P, Vilkins A, Sia M, et al. Caring for pregnant women with opioid use disorder in the USA: expanding and improving treatment. Current obstetrics and gynecology reports 2016; 5:257-63.
  58. Jones HE, Martin PR, Heil SH, Kaltenbach K, Selby P, Coyle MG, et al. Treatment of opioid-dependent pregnant women: clinical and research issues. Journal of substance abuse treatment 2008; 35(3):245-59.
  59. Krans EE, Patrick SW. Opioid use disorder in pregnancy: health policy and practice in the midst of an epidemic. Obstetrics and gynecology 2016; 128(1):4.
  60. Khanbabayi Gol M, Eidy M, Zamani Esfahlani M. Frequency ratio of carpal tunnel syndrome in women with breast cancer treated with lymphedema in Tabriz medical education centers; 2018-2019. Iran J Obstet Gynecol Infertil 2020; 22(12):62-8.
  61. Jones HE, Deppen K, Hudak ML, Leffert L, McClelland C, Sahin L, et al. Clinical care for opioid-using pregnant and postpartum women: the role of obstetric providers. American journal of obstetrics and gynecology 2014; 210(4):302-10.
  62. ACOG Committee on Obstetric Practice. ACOG Committee Opinion No. 711: opioid use and opioid use disorder in pregnancy. Obstet Gynecol 2017; 130(2):e81-94.
  63. Marques IC, Wahl TS, Chu DI. Enhanced recovery after surgery and surgical disparities. Surgical Clinics 2018; 98(6):1223-32.
  64. Ljungqvist O, Scott M, Fearon KC. Enhanced recovery after surgery: a review. JAMA surgery 2017; 152(3):292-8.
  65. Senturk JC, Kristo G, Gold J, Bleday R, Whang E. The development of enhanced recovery after surgery across surgical specialties. Journal of Laparoendoscopic & advanced surgical techniques 2017; 27(9):863-70.
  66. Hanna MN, Speed TJ, Shechter R, Grant MC, Sheinberg R, Goldberg E, et al. An innovative perioperative pain program for chronic opioid users: an academic medical center’s response to the opioid crisis. American Journal of Medical Quality 2019; 34(1):5-13.
  67. Eghdam-Zamiri R, Khanbabayi Gol M. Effects of ginger capsule on treatment of nausea and vomiting in patients receiving cisplatin undergoing mastectomy: a randomized clinical trial. Iran J Obstet Gynecol Infertil 2020; 22(11):15-21.
  68. Wijk L, Franzen K, Ljungqvist O, Nilsson K. Implementing a structured Enhanced Recovery After Surgery (ERAS) protocol reduces length of stay after abdominal hysterectomy. Acta obstetricia et gynecologica Scandinavica 2014; 93(8):749-56.
  69. Williams JB, McConnell G, Allender JE, Woltz P, Kane K, Smith PK, et al. One-year results from the first US-based enhanced recovery after cardiac surgery (ERAS Cardiac) program. The Journal of thoracic and cardiovascular surgery 2019; 157(5):1881-8.
  70. Howard R, Waljee J, Brummett C, Englesbe M, Lee J. Reduction in opioid prescribing through evidence-based prescribing guidelines. JAMA surgery 2018; 153(3):285-7.
  71. Rozental O, White RS, Weinberg R. Role of adherence to enhanced recovery after surgery programs in mitigating health care disparities. JAMA surgery 2020; 155(1):91-2.
  72. Wahl TS, Goss LE, Morris MS, Gullick AA, Richman JS, Kennedy GD, et al. Enhanced recovery after surgery (ERAS) eliminates racial disparities in postoperative length of stay after colorectal surgery. Annals of surgery 2018; 268(6):1026-35.
  73. Goss LE, Morris MS, Richman JS, Cannon JA, Kennedy GD, Simmons JW, et al. Achieving health equity in surgery through enhanced recovery after surgery (ERAS): the elimination of racial disparities in post-operative length-of-stay is sustained long-term. Clinical Nutrition ESPEN 2018; 25:178-9.
  74. White RS, Matthews KC, Tangel V, Abramovitz S. Enhanced recovery after surgery (ERAS) programs for cesarean delivery can potentially reduce healthcare and racial disparities. Journal of the National Medical Association 2019; 111(4):464.
  75. Peahl AF, Smith R, Johnson TR, Morgan DM, Pearlman MD. Better late than never: why obstetricians must implement enhanced recovery after cesarean. American journal of obstetrics and gynecology 2019; 221(2):117-e1.
  76. Egan KL, Wolfson M, Dudley WN, Francisco VT, Strack RW, Wyrick DL, et al. Diffusion of medication drop-boxes in North Carolina from 2007 to 2016. Addictive behaviors 2018; 86:44-50.
  77. Sarrazin MS, Rosenthal GE. Finding pure and simple truths with administrative data. Jama 2012; 307(13):1433-5.
مجله زنان، مامایی و نازایی ایران
دوره 26، شماره 8
آبان 1402
صفحه 90-103

فایل ها

هم رسانی

ارجاع به این مقاله

آمار